Amorphous Solid Dispersions
Visualize and control particle microstructure to improve bioavailability, stability, and manufacturability at every stage of development.
Who this is for
Drug product and process development teams working on spray‑dried dispersions (SDDs) for tablets, capsules, granules, and DPIs, especially when scaling across sites or CDMOs.
The Problem
SDD particles have complex, hollow morphologies that strongly influence dissolution, stability, tablet strength, and ultimately bioavailability and yield.
Traditional tools cannot quantify these structures at scale, so teams only see the business impact as variability: failed dissolution tests, tablet defects, site‑to‑site differences, clinical surprises.
Business Outcomes
Our Solution: Microstructure Insight Sprint
A defined 3 to 6 week engagment that combines 3D X-ray micro CT imaging and advanced AI analytics to:
Quantify
SDD morphology for thousands of particles
Identify
critical quality attributes (CQAs) that matter for dissolution, stability, and tablet quality
Link
CQAs to critical process parameters (CPPs) and manufacturing decisions
What You Get
Formulations
Studied
Transform Your Program with Microstructure Science
Get started with a drug product digital twin.
